Impact of Fish Intake Frequency on Cardiovascular Disease-Specific Survival in Hemodialysis Patients.

cardiovascular disease cardiovascular disease-specific survival fish intake frequency hemodialysis

Journal

JMA journal
ISSN: 2433-3298
Titre abrégé: JMA J
Pays: Japan
ID NLM: 101769797

Informations de publication

Date de publication:
15 Jan 2024
Historique:
received: 04 09 2023
accepted: 24 10 2023
medline: 5 2 2024
pubmed: 5 2 2024
entrez: 5 2 2024
Statut: ppublish

Résumé

Cardiovascular disease (CVD) is the leading cause of death in hemodialysis patients (HPs). As a food source, fish contains both CVD-preventive and CVD-promoting fatty acids; however, there is no consensus on fish consumption as a preventive measure for CVD in HPs. This single-center longitudinal cohort study aims to assess the impact of fish intake frequency (FIF) per week on CVD in Japanese HPs. Upon the initiation of the study, 148 HPs were evaluated to determine the FIF, and blood samples were analyzed. These patients were then monitored for 6 years.The relationships between each FIF and blood sampling data, CVD-specific survival (CSS), and new CVD-free survival (nCFS) were statistically calculated using Kaplan-Meier survival curves. During the observation period, 65 deaths were reported, 16 of which were attributed to CVD. Further, 53 patients developed new CVD onset, and no association was found between the FIF and blood sampling data. Based on the Kaplan-Meier survival curves, there was a significant difference in the CSS probability rates at 72 months between patients with an FIF of ≥4 (0.719, 95% confidence interval (CI): 0.530-0.842) and those with an FIF of ≤3 (0.930, 95% CI: 0.851-0.968) (p < 0.01). However, the nCFS probability at 72 months did not significantly differ between patients with an FIF of ≥4 and those with an FIF of ≤3. Multivariate Cox proportional hazards regression showed that an FIF of ≥4 (hazard ratio: 3.64, 95% CI: 1.22-10.9, p = 0.02) was an independent predictor of CSS, but not of nCFS. It was suggested that a higher FIF in HPs might be one of the risks for developing CVD with increased mortality.

Identifiants

pubmed: 38314428
doi: 10.31662/jmaj.2023-0135
pmc: PMC10834181
doi:

Types de publication

Journal Article

Langues

eng

Pagination

85-93

Informations de copyright

Copyright © Japan Medical Association.

Déclaration de conflit d'intérêts

None

Auteurs

Tadasuke Ando (T)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Tomochika Murakami (T)

Hemodialysis Center, JCHO Nankai Medical Center, Saiki, Japan.

Sakura Fujiyama (S)

Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Shin-Ya Sejiyama (SY)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Kan Murakami (K)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Daisuke Miki (D)

Hemodialysis Center, JCHO Nankai Medical Center, Saiki, Japan.

Yoshitsugu Fujita (Y)

Hemodialysis Center, JCHO Nankai Medical Center, Saiki, Japan.

Naomichi Yamaguchi (N)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Ryoichi Shirakami (R)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Satoki Abe (S)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Masahiro Todaka (M)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Shuntaro Suzuki (S)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Hiroyuki Fujinami (H)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Mayuka Shinohara (M)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Shinro Hata (S)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Toru Inoue (T)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Tadamasa Shibuya (T)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Toshitaka Shin (T)

Department of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Hiromitsu Mimata (H)

Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.

Classifications MeSH